Kevin is the Professor of Dietetics and Head of Department of Nutritional Sciences at King’s College London.
Kevin has undertaken extensive research on probiotics, prebiotics, fibre and dietary interventions in gastrointestinal health and disease. Kevin is the Chief Investigator of the ADDapt trial: Identifying the role of food additives in Crohn’s Disease using a randomized controlled trial of a low-emulsifier diet.
Natalie is a geneticist in the Division of Genetics and Molecular Medicine at King’s College London.
Natalie is the group leader for the IBD and Complex Genetics Groupin partnership with Guy’s and St Thomas’ NHS Hospital Trust.
Julian is Professor of Digestive Diseases at Imperial College.
Julian's research uses a variety of -omic approaches including metagenomics, metatranscriptomics, metabonomics and molecular ecology.
Ailsa is a Consultant Gastroenterologist at St Mark's Hospital and Professor of Practice at Imperial College London. Ailsa is also Director of IBD Research and Dean at St Mark’s Academic Institute.
Ailsa's research interests focus on intestinal immunology and bacteriology aiming to further our understanding of the pathogenesis of inflammatory intestinal disorders.
Nick is a Professor and consultant in Gastroenterology.
Nick's research focuses on the molecular and cellular mechanisms driving chronic intestinal inflammation, and understanding the interplay between intestinal microbes and host immunity.
James is the Professor of Inflammatory Bowel Disease at Queen Mary University of London and a Consultant Gastroenterologist at Barts Health NHS Trust.
James has extensive experience of clinical trials, cohort studies and translational science and is the Chief Investigator of the ASTICite Trial studying stem cell transplantation in patients with refractory Crohn’s Disease.
Peter is Professor of Inflammatory Bowel Disease, consultant Gastroenterologist and research lead at Guy’s and St Thomas Hospital, London. He specialises in IBD and has extensive experience as a principal investigator or steering committee member for several multinational clinical trials and investigator-led cohort studies.
Peter supervises translational laboratory science at King’s College London.